These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6217832)

  • 1. Structural characterization of factor I mediated cleavage of the third component of complement.
    Davis AE; Harrison RA
    Biochemistry; 1982 Nov; 21(23):5745-9. PubMed ID: 6217832
    [No Abstract]   [Full Text] [Related]  

  • 2. A discontinuous factor H binding site in the third component of complement as delineated by synthetic peptides.
    Lambris JD; Avila D; Becherer JD; Müller-Eberhard HJ
    J Biol Chem; 1988 Aug; 263(24):12147-50. PubMed ID: 2969896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The physiological breakdown of the third component of human complement.
    Harrison RA; Lachmann PJ
    Mol Immunol; 1980 Jan; 17(1):9-20. PubMed ID: 7360115
    [No Abstract]   [Full Text] [Related]  

  • 4. Conformational changes accompanying proteolytic cleavage of human complement protein C3b by the regulatory enzyme factor I and its cofactor H. Spectroscopic and enzymological studies.
    Isenman DE
    J Biol Chem; 1983 Apr; 258(7):4238-44. PubMed ID: 6220003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
    Davis AE; Harrison RA; Lachmann PJ
    J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
    Medicus RG; Melamed J; Arnaout MA
    Eur J Immunol; 1983 Jun; 13(6):465-70. PubMed ID: 6222909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The separation of functionally distinct forms of the third component of human complement (C3).
    Parkes C; DiScipio RG; Kerr MA; Prohaska R
    Biochem J; 1981 Mar; 193(3):963-70. PubMed ID: 6458280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited tryptic cleavage of complement factor H abrogates recognition of sialic acid-containing surfaces by the alternative pathway of complement.
    Koistinen V
    Biochem J; 1992 Apr; 283 ( Pt 2)(Pt 2):317-9. PubMed ID: 1533511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel cleavage products of the third component of human complement.
    Harrison RA; Lachmann PJ
    Mol Immunol; 1980 Feb; 17(2):219-28. PubMed ID: 6993918
    [No Abstract]   [Full Text] [Related]  

  • 10. C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I.
    Fries LF; Gaither TA; Hammer CH; Frank MM
    J Exp Med; 1984 Dec; 160(6):1640-55. PubMed ID: 6239898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic and thermodynamic analysis of the control of C3b by the complement regulatory proteins factors H and I.
    Pangburn MK; Müller-Eberhard HJ
    Biochemistry; 1983 Jan; 22(1):178-85. PubMed ID: 6219696
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of factor I by diisopropylfluorophosphate. Evidence of conformational changes in factor I induced by C3b and additional studies on the specificity of factor I.
    Ekdahl KN; Nilsson UR; Nilsson B
    J Immunol; 1990 Jun; 144(11):4269-74. PubMed ID: 2140392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited proteolysis of complement protein C3b by regulatory enzyme C3b inactivator: isolation and characterization of a biologically active fragment, C3d,g.
    Seya T; Nagasawa S
    J Biochem; 1985 Jan; 97(1):373-82. PubMed ID: 3158646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cleavage of the complement system C3 component by HIV-1 proteinase.
    Kisselev AF; Mentele R; von der Helm K
    Biol Chem; 1997 May; 378(5):439-42. PubMed ID: 9191031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and structural studies on the complement-system control protein beta 1H (Factor H).
    Sim RB; DiScipio RG
    Biochem J; 1982 Aug; 205(2):285-93. PubMed ID: 6215918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C3b inactivator and beta 1H.
    Crossley LG
    Methods Enzymol; 1981; 80 Pt C():112-24. PubMed ID: 6210825
    [No Abstract]   [Full Text] [Related]  

  • 17. Suboptimal C3b/C3bi deposition and defective yeast opsonization. I. Evidence for the absence of essential co-factor activity.
    Turner MW; Seymour ND; Kazatchkine MD; Mowbray JF
    Clin Exp Immunol; 1985 Nov; 62(2):427-34. PubMed ID: 2935338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of the complement-component-C3b-binding site and the cofactor activity for factor I in the 38kDa tryptic fragment of factor H.
    Alsenz J; Lambris JD; Schulz TF; Dierich MP
    Biochem J; 1984 Dec; 224(2):389-98. PubMed ID: 6240261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of degradation of human complement fragment, C3b.
    Sim E; Wood AB; Hsiung LM; Sim RB
    FEBS Lett; 1981 Sep; 132(1):55-60. PubMed ID: 6457754
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of complement-protein-C3b density on the binding of complement factor H to surface-bound C3b.
    Koistinen V
    Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):255-9. PubMed ID: 1835839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.